Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013 by Rezza, G et al.
1www.eurosurveillance.org
Surveillance and outbreak report 
Tick-borne encephalitis in north-east Italy: a 14-year 
retrospective study, January 2000 to December 2013
G Rezza 1 , F Farchi 1 , P Pezzotti 1 , M Ruscio 2 , A Lo Presti 1 , M Ciccozzi 1 , V Mondardini 3 , C Paternoster 4 , M Bassetti 5 , M 
Merelli 5 , PG Scotton 6 , R Luzzati 7 , J Simeoni 8 , P Mian 9 , R Mel 10 , V Carraro 11 , A Zanin 11 , R Ferretto 12 , E Francavilla 3 , TBE 
Virology Group 13 
1. Department of Infectious, Parasitic and Immunomediated Diseases, National Institute of Health, Rome, Italy
2. Unit of Laboratory Medicine, Ospedale Sant’ Antonio ASS 4 ‘Medio Friuli’, S. Daniele del Friuli, Udine, Italy
3. Division of Infectious Diseases, ULSS 1 Belluno Hospital, Belluno, Italy
4. Division of Infectious Diseases, Santa Chiara Hospital, Trento, Italy
5. Infectious Diseases Division, Santa Maria della Misericordia Hospital, Udine, Italy
6. Division of Infectious Diseases, Santa Maria di Cà Foncello Hospital, Treviso, Italy
7. Infectious Disease Unit, University Hospital of Trieste, Trieste, Italy
8. Department of Health of the Autonomous Province of South Tyrol, Bozen, Italy
9. Division of Infectious Diseases, Bolzano Hospital, Treviso, Italy
10. Department of Public Health, Belluno, Italy
11. Department of Public Health, Trento, Italy
12. Division of Infectious Diseases, Alto Vicentino Hospital, Santorso (VI), Italy
13. The members of the group are listed at the end of the article
Correspondence: Giovanni Rezza (giovanni.rezza@iss.it)
Citation style for this article: 
Rezza G, Farchi F, Pezzotti P, Ruscio M, Lo Presti A, Ciccozzi M, Mondardini V, Paternoster C, Bassetti M, Merelli M, Scotton PG, Luzzati R, Simeoni J, Mian P, Mel 
R, Carraro V, Zanin A, Ferretto R, Francavilla E. Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013. Euro 
Surveill. 2015;20(40):pii=30034. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.40.30034
Article submitted on 04 December 2014 / accepted on 11 July 2015 / published on 08 Ocotber 2015
Italy is considered at low incidence of tick-borne 
encephalitis (TBE), and the occurrence of human cases 
of TBE appears to be geographically restricted to the 
north east of the country. However, most information 
to date derives from case series, with no systematic 
data collection. To estimate incidence rates (IR) and 
spatial distribution of TBE cases, we conducted a 
retrospective study in north-eastern Italy. Data were 
collected through the infectious disease units and 
public health districts of three regions (Friuli Venezia 
Giulia, Trentino Alto Adige and Veneto) between 2000 
and 2013. Overall, 367 cases were identified (IR: 
0.38/100,000). The cases’ median age was 56 years 
and 257 (70%) were male. Central nervous system 
involvement was reported in 307 cases (84%). Annual 
fluctuations in case numbers occurred, with peaks 
in 2006 and in 2013, when 44 and 42 cases were 
respectively observed. A strong seasonality effect 
was noted, with the highest number of cases in July. 
In terms of geographical location, three main endemic 
foci with high TBE IR (> 10/100,000) were identified 
in three provinces, namely Belluno (Veneto region), 
Udine (Friuli Venezia Giulia) and Trento (Trentino Alto-
Adige). When investigating the whole study area in 
terms of altitude, the IR between 400 and 600 m was 
greater (2.41/100,000) than at other altitudes (p< 
0.01). In conclusion, the incidence of TBE in Italy is 
relatively low, even considering only the three known 
affected regions. However, three endemic foci at high 
risk were identified. In these areas, where the risk of 
TBEV infection is likely high, more active offer of TBE 
vaccination could be considered.
Introduction
Tick-borne encephalitis (TBE) is considered a disease 
of the central nervous system (CNS) caused by infec-
tion with the TBE virus (TBEV), a flavivirus discovered 
in 1937, during an expedition in Far-East Russia [1].
There are three TBEV subtypes: the European, the 
Siberian, and the Far Eastern subtype. The main hosts 
and reservoirs of TBEV are small rodent species, 
whereas ticks (Ixodes persulcatus and I. ricinus) act 
as the vector [2]. The principal vector of the European 
TBEV subtype is I. ricinus.
The clinical manifestations of TBE usually start with a 
febrile illness, but ca 20 to 30% of the patients sub-
sequently develop CNS disease, such as meningitis or 
encephalitis [2-4]. Thus, the neurological manifestation 
defining the syndromic picture of TBE underrepresent 
the overall clinical burden of disease related to TBEV 
infection.
The natural habitat of TBEV is represented by the forests 
of Europe and Asia. In the European continent, TBEV is 
distributed in an endemic pattern of so-called natural 
foci over central and north-eastern Europe, with the 
highest incidence (> 10 cases/100,000) in Baltic coun-
tries, the Czech Republic, Russia, and Slovenia [5]. In 
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Austria, which is the only country with a significantly 
decreasing trend of TBE cases, due to mass vaccination 
programmes, the incidence in the unvaccinated popu-
lation is ca five per 100,000 [5,6].
Italy is considered a country with geographically 
restricted, low incidence of TBE [6]. The disease is not 
notifiable in the country but individuals with TBE can be 
reported at the regional level, where they are classified 
as ‘viral meningitis and encephalitis’ (notifiable dis-
eases, class 2). Although the extent of affected areas 
in Italy is not well defined, the regions of the north 
east appear to be those where cases have been docu-
mented, as suggested by case series of TBE published 
in the last decade [7-10]. However, to the best of our 
knowledge, systematic information on the occurrence 
of persons with TBE is lacking even in these affected 
areas of Italy, and both the incidence rates (IR) and the 
geographical distribution of persons with the disease 
have been mostly derived from international literature 
or reports of aggregated cases [6].
In the European Union (EU), TBE was added to the 
list of notifiable diseases in 2012 with a harmonised 
case definition focused on neuroinvasive illness with 
laboratory confirmation [11], highlighting the need of 
detailed epidemiological data.
To fill the gap in knowledge about TBE distribution 
in Italy, we conducted a retrospective study in three 
affected regions (Friuli Venezia Giulia, Trentino Alto 
Adige and Veneto) in the north-east of the country. The 
study was aimed at estimating the incidence of TBE 
(including febrile illness and/or CNS disease) in these 
regions from 2000 to 2013. We also sought to iden-
tify at risk areas within the affected regions, and to 
describe demographic parameters of TBE cases. Some 
environmental factors were also investigated.
Methods
Study area
The study was conducted in three north-eastern Italian 
regions: Friuli Venezia Giulia, Trentino-Alto Adige (i.e. 
the autonomous provinces of Trento and Bolzano), 
and Veneto. Together, these regions, which cover 
39,728 km2, and at the beginning of 2013 comprised 
around 7.1 million inhabitants, are commonly referred 
to as ‘Triveneto’. The northern and eastern parts of 
the ‘Triveneto’ area border with Austria and Slovenia 
respectively and have a mountainous landscape (the 
Alps), while the southern part comprises the east-
ern part of the Po valley. The area is administratively 
divided in around 1,130 municipalities and their alti-
tude shows a strong gradient increasing from south to 
north. The study area was identified as that of major 
interest for TBE through a literature review (i.e. PubMed 
search using ‘tick-borne encephalitis’ or ‘TBE’ or ‘TBEV’ 
and ‘Italy’ as keywords, in addition to revision of grey 
literature, such as national and EU reports), and con-
sultations with experts in the field. Entomological data 
(i.e. the distribution of TBEV infected ticks) was also 
revised using a similar approach (PubMed searches, 
examination of grey literature as well as reliance on 
expert opinion). On the basis of this information, the 
expected area of interest for TBE was only a fraction 
of the three regions; however, we included contiguous 
areas in the study, to exclude the occurrence of autoch-
thonous cases, and to identify possible cases in indi-
viduals travelling to, and/or spending their vacations in 
the affected areas. Public health authorities and clini-
cians of other regions of northern Italy (i.e. those bor-
dering regions or countries reporting TBE cases) were 
also contacted during the study to exclude the pres-
ence of known persons affected by TBE.
Data collection
To gather information on cases of TBE diagnosed 
between January 2000 and December 2013, all the 
infectious diseases units and public health districts 
in the study area were contacted. Study visits were 
planned to support clinicians in standardised data 
collection. Clinical registers were accurately checked; 
Characteristics N (%)a
Nationality 
Italians 355 (96.7)
Others 12 (3.3)
Area of residence 
Living in north-eastern Italy 364 (99.2)
Living in other areas 3 (0.8)
Sex 
Female 110 (30.0)
Male 257 (70.0)
Age Median (IQR) 56 (42–67)
Month of onset 
symptoms 
January 2 (0.5)
February 1 (0.3)
March 3 (0.8)
April 25 (6.8)
May 50 (13.6)
June 64 (17.4)
July 79 (21.5)
August 44 (12.0)
September 32 (8.7)
October 53 (14.4)
November 11 (3.0)
December 3 (0.8)
Clinical syndrome 
Encephalitis 175 (47.7)
Meningoencephalitis 94 (25.6)
Febrile illness only 60 (16.4)
Aseptic meningitis 25 (6.8)
Meningoencephalomyelitis 13 (3.5)
Vaccinated – 3 (0.8)
Sequelae – 60 (16.3)
Deaths – 2 (0.5)
Table 1
Descriptive characteristics of persons diagnosed with 
tick-borne encephalitis in ‘Triveneto’, north-eastern Italy, 
2000–2013 (n=367)
IQR: interquartile range.
a Unless otherwise specified.
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when needed, laboratory registries were revised by 
trained staff. Collection of information on TBE affected 
persons was guided by a questionnaire relating to 
demographic data (age, sex, place of residence, and 
nationality), clinical information (i.e. febrile illness, 
meningitis, encephalitis, meningoencephalitis, other 
neurological symptoms), and presumed place of expo-
sure to tick bite. When available from the clinical regis-
ter, data on environmental factors or behaviour, which 
could potentially have led to tick exposure were also 
gathered.
Case definition
To the purpose of this study, we adopted a case defi-
nition based on clinical and epidemiological criteria, 
similar to some of those used in other EU Member 
States [11].
A case of TBE was defined by the presence of a febrile 
illness, with/without encephalitis, meningitis, menin-
goencephalitis or meningoencephalomyelitis, and 
laboratory criteria (i.e. specific IgM and IgG response 
to TBEV, or seroconversion, or fourfold increase in IgG, 
or detection of TBEV nucleic acid by polymerase chain 
reaction).
Statistical analysis
Descriptive techniques, such as frequency distribu-
tions, percentages, medians, and interquartile ranges, 
were used to summarise the data. As measure of TBE 
occurrence, IRs were then calculated as the number of 
cases per 100,000 individuals of population at risk. 
This population was considered that reported by the 
Italian National Bureau of Census (www.demo.istat.it) 
as individuals living at the beginning of each year in the 
study regions. IRs were also stratified by province and 
municipality of residence. The temporal trend was eval-
uated using Poisson regression; incidence rate ratios 
(IRR) per one calendar year were then calculated. IRRs 
by Poisson regression were also calculated to evaluate 
the association with the altitude of the municipality. IR 
per municipality of residence were graphically repre-
sented as geographical maps.
Results
During the period from 2000 to 2013, 367 cases 
(0.38/100,000 inhabitants) were diagnosed in the study 
area. Table 1 shows the main characteristics of the 
cases. Almost all of them (n=355) were Italian nation-
als and a majority of cases (n=364) was also resid-
ing in the study area; cases were mainly male (n=257; 
70%), and around 70% (n=255) were between 30 and 
Figure 1
Monthly distribution of tick-borne encephalitis cases in ‘Triveneto’, north-eastern Italy, 2000–2013 (n=367 cases)
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70 years-old. Encephalitis was the most common clini-
cal presentation (n=175 cases), while febrile syndrome 
without CNS involvement (n=60 cases) accounted for 
less than a sixth of the cases. Symptom onset occurred 
mainly between April and October (n=347 cases; 
94.5%). Almost all cases (n=364) were not vaccinated 
and whether full vaccination was achieved among 
those who were is not known. Sequelae were reported 
in 60 (16.3%) individuals. Of them, 23 developed 
tiredness, 19 paresis, 11 tremor, seven headache, six 
memory and/or concentration disturbances, three pain 
in the extremities; insomnia, anxiety, or nausea were 
reported by two patients, respectively, whereas hear-
ing disturbance, dizziness, or electroencephalography 
anomalies only by one (data not shown in table). Two 
cases died (case fatality rate: 0.5%).
Modality of tick bite exposure was available for 156 of 
the 367 cases. Recreational activities were mentioned 
by 111 cases; of them, some specified trekking (n=25), 
mushrooming (n=16), whereas only five hunting. Living 
in a high risk area was reported by 32 individuals (for 6 
of them it was a summer house). Nine cases were agri-
cultural workers. Finally, four cases reported probable 
tick-bites while abroad (2 in Austria and 2 in Slovenia, 
respectively). 
Figure 1 shows the distribution of the number of cases 
per month, during the study period. A strong seasonal-
ity could be observed, with the number of cases usu-
ally peaking in July, and in large part occurring between 
April and October (see also Table 1). Considering the 
annual IR, a significant temporal increase was observed 
during the study period, with annual IR increasing from 
0.18 in the year 2000 to 0.59 per 100,000 in 2013 
(IRR = 1.05 per one calendar year increase; 95% confi-
dence interval (CI): 1.02–1.08, p < 0.01) (data not shown 
in Figure 1); however, the overall increase was mainly 
Figure 2
Annual incidence rates (per 100,000 inhabitants) of tick-borne encephalitis cases by municipalities of residence in north-
eastern Italy, 2000–2013
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due to the change in incidence that occurred between 
2003 (IR: 0.25/100,000) and 2004 (IR: 0.48/100,000). 
In fact, after excluding the years before 2004, the 
estimated IRR was 1.01 (95%CI: 0.97–1.05, p = 0.64). 
Similar results were obtained when excluding from 
the analysis cases with only febrile illness (data not 
shown).
Figure 2 shows the map of the mean annual IR by 
municipality of residence. Noteworthy, the municipal-
ity with the highest IR in the entire area was Tramonti 
di Sopra (181.2/100,000) in the province of Pordenone. 
At the province level, the map clearly identifies three 
provinces with the highest IR: Belluno province (Veneto 
region), of which the municipality of Limana presented 
the highest IR (35.9/100,000), Udine province (Friuli 
Venezia Giulia region), with the municipality of Resiutta 
having the highest IR (42.6), and the Trento prov-
ince (Trentino Alto-Adige region), with the highest IR 
observed in the municipality of Tres (41.6). The highest 
number of cases was also reported in these three prov-
inces; in particular, the most affected municipalities 
were Belluno (n=49 cases), Limana (n=24), and Ponte 
nelle Alpi (n=17), all located in the province of Belluno 
(data not shown). 
Table 2 summarises the number of cases, the estimated 
IR, and the IRR, after stratifying the municipalities of 
residence by altitude. Overall, there was a significant 
association in terms of altitude, with the lowest IR value 
in municipalities at an altitude ≤ 200 m and the highest 
in municipalities between 400 and 600 m. For altitudes 
above 600 m, IR decreased with further municipality 
altitude increase; however, the IR for municipalities 
with a mean altitude > 800 m remained five times sig-
nificantly higher than for municipalities with a mean 
altitude of ≤ 200 m.
Discussion
Italy is considered a country at low risk for TBE, which 
appears to be restricted to a relatively small fraction 
of its territory. However to date, accurate informa-
tion on the occurrence of TBE and/or TBEV infection 
in Italy is not available, and the major source of data 
has originated from case reports or case series [6-10], 
all from the north-eastern regions, and especially 
from areas bordering high incidence countries such 
as Austria and Slovenia. Thus, our data allow, for the 
first time, to accurately calculate incidence rates and 
to describe the geographical distribution of TBE cases 
in the affected Italian areas.
The total number and IR of cases found in our study 
appear to be much higher than that reported in the 
past, presumably from the same geographical area. 
For example, according to an article summarising data 
from different European countries, only 102 cases were 
observed in Italy in the period from 1975 to 2001; of 
these, 14 occurred between 1975 and 1991, and 88 
from 1992 to 2001 [12]. However, a direct comparison 
with these data is not possible, since their source and 
the study area were not well defined.
We found an IR of ca 0.4 per 100,000 in the overall 
study area. However, at the level of the most affected 
provinces of Trento, Belluno, and Udine, the IR ranged 
between 1 and 5 per 100,000 which appears to be lower 
than that reported in neighbouring countries such as 
Austria (before mass vaccination) and Slovenia [6]. In 
particular, incidence rates of 17.9 per 100,000 (ranging 
from 1.2 to 42.8/100,000 over the last four decades) 
and eight per 100,000 have been reported respectively 
in the unvaccinated population of Carinthia and Tirol, 
two Austrian regions bordering ‘Triveneto’ [13].
The annual number of cases observed in ‘Triveneto’ 
tended to vary, showing two peaks respectively in 
2006 and 2013, whereas the lowest number of cases 
was registered in 2002. Yearly trend fluctuations were 
observed also in other countries such as Switzerland, 
where a study from 2005 to 2011 found the lowest and 
the highest number of cases in 2002 and 2006, respec-
tively [14].
Most cases occurred between April and October, with 
peaks in June and July. This is rather consistent with 
the seasonality of tick activity, with slight differences 
compared with central Europe, where seasonal peaks 
Municipality altitude 
(metres)
Number of 
municipalities
Municipalities with at 
least one case 
N (%)
Total TBE 
cases
IR (per 
100,000)
IRR 
(95% CI) P-value
a
0–200 589 44 (7.5) 78 0.10 1.00 (–) < 0.01
200–400 146 40 (27.4) 162 1.54 15.16 (11.57–19.86) < 0.01
400–600 101 22 (21.8) 70 2.41 23.81 (17.24–32.87) –
600–800 103 15 (14.6) 28 1.27 12.52 (8.13–19.27) < 0.01
 > 800 196 17 (8.7) 26 0.55 5.42 (3.48- 8.45) < 0.01
Table 2
Incidence rates (IR) and incidence rate ratios (IRR) of tick-borne encephalitis (TBE) in ‘Triveneto’ according to the altitude 
of the municipalities of residence, north-eastern Italy, 2000–2013
a P-values refer to comparisons between IR in municipalities with a mean altitude between 400 and 600 m with that of the municipalities with 
another mean altitude.
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of feeding activity of ticks tend to occur between May 
and June, and between September and October [1].
The demographic characteristics of our patients, show-
ing male predominance and rather advanced median 
age, were similar to those observed in neighbouring 
countries such as Switzerland, where TBE incidence 
peaked in 60–69 year-olds, and male predominance 
was observed in all age groups [14].
Most cases were concentrated in three main foci, 
one in the autonomous province of Trento, one in the 
pre-alpine Belluno province of Veneto, and one at the 
extreme north-east of Friuli Venezia Giulia. In this 
respect, it should be underlined that TBEV epidemiol-
ogy is closely associated with ticks’ ecology, and that 
ticks inhabit specific foci in the forests with enhanced 
moist vegetation and wild animals supplying blood 
meals for them [1]. The special combination of climatic 
conditions, including temperature, moisture, and veg-
etation, occurring only within specific geographical 
zones, provides an heterogeneous tick distribution, 
generating as many as 20,000 or even 30,000 esti-
mated natural foci of TBEV infections across the north-
ern hemisphere [1].
The heterogeneous geographical distribution of human 
cases in our study appears to be consistent with that 
of competent vectors, as suggested by entomological 
studies conducted in the same area. To this regard, 
TBEV was detected in 2.1% of 193 ticks collected in 14 
sites of north-eastern Italy between April and June in 
the years 2006 to 2008 [15]. Further studies showed 
that the density distribution of competent ticks and 
the prevalence of TBEV infection is not homogeneously 
distributed within the affected regions. In fact, 0.21% 
of 2,361 of I. ricinus ticks collected in the alpine area of 
the extreme north-eastern Italy (Friuli Venezia Giulia) 
between 2005 and 2006 were positive for TBEV, but 
all of them were found in three sites where the highest 
tick density was found [16].
Recreational activities were found to be the most 
common possible exposure to tick bite in our study; 
however, almost all the cases were reported among 
residents. This might be due to the fact that, though 
the Alps represent a touristic area, tourists tend to 
spend their vacations at higher altitudes than those 
found to be at highest risk. To this regard, a case–con-
trol study conducted in Poland found that, in endemic 
areas, the highest TBE risk was associated with spend-
ing at least 10 hours a week in mixed forests and har-
vesting forest foods, being unemployed, or employed 
as a forester [17].
TBEV infection may be prevented not only adopting 
behavioural precautions, but also by using effective 
vaccines. In our study, only three individuals reported 
having been vaccinated against TBE; however, whether 
they had completed the full vaccination schedule 
is unknown. In Austria, data collected in the period 
between 1972 and 2011 showed that mass vaccina-
tion reduced incidence to ca 16% of that of the pre-
vaccination era: average incidence declined from 5.7 
per 100,000 in the first ten years to 0.9 per 100,000 
in the last decade of the study, while TBE vaccination, 
which started in 1972, reached 88% in 2005 [18]. TBE 
vaccination is recommended to high risk population 
groups (foresters, scouts, persons with hobbies or 
leisure activities potentially leading to tick exposure) 
in Veneto and in Trentino Alto Adige. In Friuli Venezia 
Giulia, vacccination has been offered free of charge to 
all the population of the region since 2013; however, 
whether vaccination had any impact on the disease 
burden in north-eastern Italy remains undefined.
Before drawing conclusions, some limits and possible 
biases of our study should be mentioned. Firstly, our 
case-definition included also febrile illness without 
CNS involvement. This may supply a more comprehen-
sive figure of TBE cases and their distribution, but it 
makes the data less reliable since a large proportion 
of febrile cases could have not been diagnosed; more-
over, the proportion of undetected cases may vary 
unpredictably in time and space. Secondly, we cannot 
rule out completely the presence of TBE foci in other 
Italian regions. To this purpose, it should be reminded 
that in the 1970s, a few TBE cases and infected ticks 
were found in Tuscany [19,20]. However, recent stud-
ies on the aetiology of meningoencephalitis have not 
confirmed these findings (data not shown). Moreover, 
studies of forestry rangers showed a seropositivity 
of 0.6% for TBE in the north-eastern region of Friuli 
Venezia Giulia [21], while none of those investigated in 
Tuscany or Lazio (both regions are located in central 
Italy) had TBE antibodies [22,23]. Finally, we cannot 
exclude completely the occurrence of a few cases in 
other regions of northern Italy, such as Lombardy, bor-
dering Switzerland, another country at relatively high 
incidence of TBE. However, as reported above, active 
surveillance failed to identify human cases of TBE. 
These findings highly suggest that TBEV infection is 
restricted to the north-eastern area of the country, and 
it does not seem for the moment to expand its range 
to other Italian areas. The absence of cases away from 
the Alps area, even in the surveyed provinces of the 
three affected regions of north-eastern Italy, strength-
ens this argument.
In conclusion, seasonal occurrence of human cases 
of TBE in three regions of north-eastern Italy is con-
firmed. The incidence is relatively low, when compared 
with other countries in central and northern Europe. 
However, three endemic foci where risk of TBEV infec-
tion is likely high, were identified. Moreover the high-
est IRs were between 400 and 600 m of altitude. Most 
cases were detected among residents performing recre-
ational activities. More active offer of anti-TBE vaccine 
to people living in high risk areas might be considered.
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